US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist

0.408
+0.013+3.16%

Trading Jul 23 14:01 ET

84.58MMarket Cap-217P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

26.60%-48.66M

-0.54%-224.84M

11.41%-50.54M

11.80%-47.29M

-12.46%-60.71M

-12.42%-66.3M

4.13%-223.63M

-8.22%-57.05M

9.76%-53.62M

-2.70%-53.99M

Net income from continuing operations

-332.29%-49.09M

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.84%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.48%-43.17M

Depreciation and amortization

-54.74%2.53M

7.93%22.19M

-44.69%3.01M

43.22%7.42M

23.57%6.18M

13.02%5.58M

16.58%20.56M

11.96%5.44M

12.83%5.18M

16.65%5M

Deferred tax

----

---6.34M

---140K

--182K

----

--0

----

Other non cash items

----

--1.12M

--0

----

Change In working capital

94.40%-8.9M

-99.27%-164.03M

104.39%783K

79.29%-2.67M

85.99%-3.33M

-471.46%-158.81M

19.21%-82.32M

19.45%-17.85M

48.02%-12.91M

-18.71%-23.78M

-Change in receivables

116.38%586K

66.51%3.15M

-25.96%425K

75.50%2.19M

310.17%4.11M

-283.80%-3.58M

1,934.95%1.89M

-74.20%574K

238.64%1.25M

990.22%1M

-Change in prepaid assets

-112.58%-783K

224.93%6.13M

3.73%974K

54.56%-389K

85.79%-675K

2,682.16%6.22M

31.58%-4.91M

232.63%939K

57.75%-856K

-72.08%-4.75M

-Change in payables and accrued expense

28.62%-7.5M

-58.13%5.59M

176.80%10.81M

-38.32%6.33M

76.37%-1.05M

-391.05%-10.5M

274.16%13.35M

231.70%3.91M

786.62%10.27M

-808.96%-4.43M

-Change in other current liabilities

-0.84%-1.2M

-123.96%-5.06M

-251.53%-1.43M

-6.95%-1.23M

-9.55%-1.2M

-24.87%-1.19M

27.72%-2.26M

185.83%945K

-25.24%-1.15M

-27.94%-1.1M

-Change in other working capital

----

-92.33%-173.85M

58.72%-9.99M

57.30%-9.57M

68.84%-4.52M

-411.60%-149.77M

-7.83%-90.39M

-23.48%-24.21M

-14.98%-22.41M

15.35%-14.5M

Cash from discontinued investing activities

Operating cash flow

26.60%-48.66M

-0.54%-224.84M

11.41%-50.54M

11.80%-47.29M

-12.46%-60.71M

-12.42%-66.3M

4.13%-223.63M

-8.22%-57.05M

9.76%-53.62M

-2.70%-53.99M

Investing cash flow

Cash flow from continuing investing activities

0.31%35.84M

158.97%153.53M

-11.51%37.71M

379.51%37.63M

49.38%42.47M

1,995.48%35.73M

-76.11%59.29M

-19.04%42.61M

-122.08%-13.46M

-68.16%28.43M

Net PPE purchase and sale

--0

-4.88%-21.16M

64.26%-2.67M

37.82%-2.74M

-1.74%-5.54M

-259.28%-10.2M

13.35%-20.17M

-161.51%-7.47M

15.25%-4.41M

25.03%-5.45M

Net business purchase and sale

----

--0

----

--0

----

Net investment purchase and sale

-21.96%35.84M

119.85%174.69M

-19.38%40.38M

546.14%40.37M

41.73%48.01M

910.74%45.93M

-70.74%79.46M

-9.74%50.09M

-113.67%-9.05M

-64.94%33.87M

Cash from discontinued investing activities

Investing cash flow

0.31%35.84M

158.97%153.53M

-11.51%37.71M

379.51%37.63M

49.38%42.47M

1,995.48%35.73M

-76.11%59.29M

-19.04%42.61M

-122.08%-13.46M

-68.16%28.43M

Financing cash flow

Cash flow from continuing financing activities

176.46%22.12M

-82.77%14.59M

-99.15%167K

-100.23%-100K

-71.50%6.52M

610.66%8M

157.65%84.66M

824.95%19.54M

697.85%43.82M

128.31%22.87M

Net common stock issuance

147.22%22.52M

-82.20%15.11M

-104.02%-719K

-98.40%720K

-72.67%5.99M

--9.11M

213.18%84.87M

--17.91M

823.58%45.03M

233.67%21.93M

Proceeds from stock option exercised by employees

----

-50.66%935K

-47.20%935K

33.49%-719K

----

-78.98%1.9M

-25.65%1.77M

-222.98%-1.08M

-71.28%1.13M

Net other financing activities

63.75%-402K

30.94%-1.45M

65.49%-49K

25.19%-101K

-4.30%-194K

32.42%-1.11M

35.42%-2.1M

47.41%-142K

48.67%-135K

62.12%-186K

Cash from discontinued financing activities

Financing cash flow

176.46%22.12M

-82.77%14.59M

-99.15%167K

-100.23%-100K

-71.50%6.52M

610.66%8M

157.65%84.66M

824.95%19.54M

697.85%43.82M

128.31%22.87M

Net cash flow

Beginning cash position

-54.19%46.7M

-43.48%101.94M

-39.61%58.01M

-42.68%68.33M

-34.51%79.74M

-43.48%101.94M

35.79%180.37M

-46.17%96.07M

-30.44%119.21M

-2.18%121.76M

Current changes in cash

141.20%9.3M

28.81%-56.72M

-348.34%-12.66M

58.02%-9.77M

-337.14%-11.72M

61.64%-22.57M

-266.68%-79.68M

150.81%5.1M

-430.05%-23.26M

-105.74%-2.68M

Effect of exchange rate changes

-282.56%-670K

18.26%1.48M

74.58%1.35M

-533.07%-550K

140.77%313K

65.32%367K

576.81%1.25M

773.91%775K

353.57%127K

-14.47%130K

End cash Position

-30.61%55.33M

-54.19%46.7M

-39.61%58.01M

-42.68%68.33M

-34.51%79.74M

-43.48%101.94M

-46.17%96.07M

-30.44%119.21M

Free cash flow

36.39%-48.66M

-0.90%-246M

17.53%-53.21M

13.78%-50.04M

-11.48%-66.25M

-23.76%-76.5M

4.96%-243.8M

-16.11%-64.52M

10.21%-58.03M

0.67%-59.43M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	26.60%-48.66M	-0.54%-224.84M	11.41%-50.54M	11.80%-47.29M	-12.46%-60.71M	-12.42%-66.3M	4.13%-223.63M	-8.22%-57.05M	9.76%-53.62M	-2.70%-53.99M
Net income from continuing operations	-332.29%-49.09M	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.84%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.48%-43.17M
Depreciation and amortization	-54.74%2.53M	7.93%22.19M	-44.69%3.01M	43.22%7.42M	23.57%6.18M	13.02%5.58M	16.58%20.56M	11.96%5.44M	12.83%5.18M	16.65%5M
Deferred tax	----	---6.34M	---140K	--182K	----	----	--0	--0	--0	----
Other non cash items	----	--1.12M	--0	----	----	----	----	----	----	----
Change In working capital	94.40%-8.9M	-99.27%-164.03M	104.39%783K	79.29%-2.67M	85.99%-3.33M	-471.46%-158.81M	19.21%-82.32M	19.45%-17.85M	48.02%-12.91M	-18.71%-23.78M
-Change in receivables	116.38%586K	66.51%3.15M	-25.96%425K	75.50%2.19M	310.17%4.11M	-283.80%-3.58M	1,934.95%1.89M	-74.20%574K	238.64%1.25M	990.22%1M
-Change in prepaid assets	-112.58%-783K	224.93%6.13M	3.73%974K	54.56%-389K	85.79%-675K	2,682.16%6.22M	31.58%-4.91M	232.63%939K	57.75%-856K	-72.08%-4.75M
-Change in payables and accrued expense	28.62%-7.5M	-58.13%5.59M	176.80%10.81M	-38.32%6.33M	76.37%-1.05M	-391.05%-10.5M	274.16%13.35M	231.70%3.91M	786.62%10.27M	-808.96%-4.43M
-Change in other current liabilities	-0.84%-1.2M	-123.96%-5.06M	-251.53%-1.43M	-6.95%-1.23M	-9.55%-1.2M	-24.87%-1.19M	27.72%-2.26M	185.83%945K	-25.24%-1.15M	-27.94%-1.1M
-Change in other working capital	----	-92.33%-173.85M	58.72%-9.99M	57.30%-9.57M	68.84%-4.52M	-411.60%-149.77M	-7.83%-90.39M	-23.48%-24.21M	-14.98%-22.41M	15.35%-14.5M
Cash from discontinued investing activities
Operating cash flow	26.60%-48.66M	-0.54%-224.84M	11.41%-50.54M	11.80%-47.29M	-12.46%-60.71M	-12.42%-66.3M	4.13%-223.63M	-8.22%-57.05M	9.76%-53.62M	-2.70%-53.99M
Investing cash flow
Cash flow from continuing investing activities	0.31%35.84M	158.97%153.53M	-11.51%37.71M	379.51%37.63M	49.38%42.47M	1,995.48%35.73M	-76.11%59.29M	-19.04%42.61M	-122.08%-13.46M	-68.16%28.43M
Net PPE purchase and sale	--0	-4.88%-21.16M	64.26%-2.67M	37.82%-2.74M	-1.74%-5.54M	-259.28%-10.2M	13.35%-20.17M	-161.51%-7.47M	15.25%-4.41M	25.03%-5.45M
Net business purchase and sale	----	--0	----	----	----	----	--0	----	----	----
Net investment purchase and sale	-21.96%35.84M	119.85%174.69M	-19.38%40.38M	546.14%40.37M	41.73%48.01M	910.74%45.93M	-70.74%79.46M	-9.74%50.09M	-113.67%-9.05M	-64.94%33.87M
Cash from discontinued investing activities
Investing cash flow	0.31%35.84M	158.97%153.53M	-11.51%37.71M	379.51%37.63M	49.38%42.47M	1,995.48%35.73M	-76.11%59.29M	-19.04%42.61M	-122.08%-13.46M	-68.16%28.43M
Financing cash flow
Cash flow from continuing financing activities	176.46%22.12M	-82.77%14.59M	-99.15%167K	-100.23%-100K	-71.50%6.52M	610.66%8M	157.65%84.66M	824.95%19.54M	697.85%43.82M	128.31%22.87M
Net common stock issuance	147.22%22.52M	-82.20%15.11M	-104.02%-719K	-98.40%720K	-72.67%5.99M	--9.11M	213.18%84.87M	--17.91M	823.58%45.03M	233.67%21.93M
Proceeds from stock option exercised by employees	----	-50.66%935K	-47.20%935K	33.49%-719K	----	----	-78.98%1.9M	-25.65%1.77M	-222.98%-1.08M	-71.28%1.13M
Net other financing activities	63.75%-402K	30.94%-1.45M	65.49%-49K	25.19%-101K	-4.30%-194K	32.42%-1.11M	35.42%-2.1M	47.41%-142K	48.67%-135K	62.12%-186K
Cash from discontinued financing activities
Financing cash flow	176.46%22.12M	-82.77%14.59M	-99.15%167K	-100.23%-100K	-71.50%6.52M	610.66%8M	157.65%84.66M	824.95%19.54M	697.85%43.82M	128.31%22.87M
Net cash flow
Beginning cash position	-54.19%46.7M	-43.48%101.94M	-39.61%58.01M	-42.68%68.33M	-34.51%79.74M	-43.48%101.94M	35.79%180.37M	-46.17%96.07M	-30.44%119.21M	-2.18%121.76M
Current changes in cash	141.20%9.3M	28.81%-56.72M	-348.34%-12.66M	58.02%-9.77M	-337.14%-11.72M	61.64%-22.57M	-266.68%-79.68M	150.81%5.1M	-430.05%-23.26M	-105.74%-2.68M
Effect of exchange rate changes	-282.56%-670K	18.26%1.48M	74.58%1.35M	-533.07%-550K	140.77%313K	65.32%367K	576.81%1.25M	773.91%775K	353.57%127K	-14.47%130K
End cash Position	-30.61%55.33M	-54.19%46.7M	-54.19%46.7M	-39.61%58.01M	-42.68%68.33M	-34.51%79.74M	-43.48%101.94M	-43.48%101.94M	-46.17%96.07M	-30.44%119.21M
Free cash flow	36.39%-48.66M	-0.90%-246M	17.53%-53.21M	13.78%-50.04M	-11.48%-66.25M	-23.76%-76.5M	4.96%-243.8M	-16.11%-64.52M	10.21%-58.03M	0.67%-59.43M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall